Clovis Oncology (CLVS) Posts Q2 Loss of 61c/Share, Narrower than Views

Clovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($0.61), $0.09 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results